Phillip D. Holler, Ph.D. - Publications

Affiliations: 
2002 University of Illinois, Urbana-Champaign, Urbana-Champaign, IL 
Area:
Biochemistry, Immunology

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Chervin AS, Stone JD, Holler PD, Bai A, Chen J, Eisen HN, Kranz DM. The impact of TCR-binding properties and antigen presentation format on T cell responsiveness. Journal of Immunology (Baltimore, Md. : 1950). 183: 1166-78. PMID 19553539 DOI: 10.4049/jimmunol.0900054  0.44
2007 Feuerer M, Jiang W, Holler PD, Satpathy A, Campbell C, Bogue M, Mathis D, Benoist C. Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes. Proceedings of the National Academy of Sciences of the United States of America. 104: 18181-6. PMID 17991775 DOI: 10.1073/pnas.0708899104  0.44
2007 Holler PD, Yamagata T, Jiang W, Feuerer M, Benoist C, Mathis D. The same genomic region conditions clonal deletion and clonal deviation to the CD8alphaalpha and regulatory T cell lineages in NOD versus C57BL/6 mice. Proceedings of the National Academy of Sciences of the United States of America. 104: 7187-92. PMID 17438291 DOI: 10.1073/pnas.0701777104  0.44
2007 Brophy SE, Jones LL, Holler PD, Kranz DM. Cellular uptake followed by class I MHC presentation of some exogenous peptides contributes to T cell stimulatory capacity. Molecular Immunology. 44: 2184-94. PMID 17169430 DOI: 10.1016/j.molimm.2006.11.016  1
2006 Ge Q, Holler PD, Mahajan VS, Nuygen T, Eisen HN, Chen J. Development of CD4+ T cells expressing a nominally MHC class I-restricted T cell receptor by two different mechanisms. Proceedings of the National Academy of Sciences of the United States of America. 103: 1822-7. PMID 16443680 DOI: 10.1073/pnas.0510561103  0.44
2005 Chlewicki LK, Holler PD, Monti BC, Clutter MR, Kranz DM. High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3. Journal of Molecular Biology. 346: 223-39. PMID 15663940 DOI: 10.1016/j.jmb.2004.11.057  1
2004 Peng KW, Holler PD, Orr BA, Kranz DM, Russell SJ. Targeting virus entry and membrane fusion through specific peptide/MHC complexes using a high-affinity T-cell receptor. Gene Therapy. 11: 1234-9. PMID 15215883 DOI: 10.1038/sj.gt.3302286  1
2004 Holler PD, Kranz DM. T cell receptors: affinities, cross-reactivities, and a conformer model. Molecular Immunology. 40: 1027-31. PMID 15036906 DOI: 10.1016/j.molimm.2003.11.013  1
2003 Leifert JA, Holler PD, Harkins S, Kranz DM, Whitton JL. The cationic region from HIV tat enhances the cell-surface expression of epitope/MHC class I complexes. Gene Therapy. 10: 2067-73. PMID 14595379 DOI: 10.1038/sj.gt.3302115  1
2003 Holler PD, Kranz DM. Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity. 18: 255-64. PMID 12594952  1
2003 Brophy SE, Holler PD, Kranz DM. A yeast display system for engineering functional peptide-MHC complexes. Journal of Immunological Methods. 272: 235-46. PMID 12505727  1
2003 Holler PD, Chlewicki LK, Kranz DM. TCRs with high affinity for foreign pMHC show self-reactivity. Nature Immunology. 4: 55-62. PMID 12469116 DOI: 10.1038/ni863  1
2001 Holler PD, Lim AR, Cho BK, Rund LA, Kranz DM. CD8(-) T cell transfectants that express a high affinity T cell receptor exhibit enhanced peptide-dependent activation. The Journal of Experimental Medicine. 194: 1043-52. PMID 11602635  1
2000 Shusta EV, Holler PD, Kieke MC, Kranz DM, Wittrup KD. Directed evolution of a stable scaffold for T-cell receptor engineering. Nature Biotechnology. 18: 754-9. PMID 10888844 DOI: 10.1038/77325  1
2000 Holler PD, Holman PO, Shusta EV, O'Herrin S, Wittrup KD, Kranz DM. In vitro evolution of a T cell receptor with high affinity for peptide/MHC. Proceedings of the National Academy of Sciences of the United States of America. 97: 5387-92. PMID 10779548 DOI: 10.1073/pnas.080078297  0.44
1999 Rund LA, Cho BK, Manning TC, Holler PD, Roy EJ, Kranz DM. Bispecific agents target endogenous murine T cells against human tumor xenografts. International Journal of Cancer. Journal International Du Cancer. 83: 141-9. PMID 10449621 DOI: 10.1002/(SICI)1097-0215(19990924)83:1<141::AID-IJC24>3.0.CO;2-0  0.44
Show low-probability matches.